Vaccines Industry “Booming”
Health News November 23rd, 2009
Malaria, tuberculosis, AIDS, pandemic flu, herpes, Alzheimer’s, allergies, until diarrhea. Call it the amount of disease that often affects humans, the pharmaceutical industry are now actively researching a variety of vaccines to prevent it. Most of these vaccines are expected to circulate in the market within the next 5 years.
The development of vaccine technology in the world is growing rapidly. This gives a glimmer of hope for tackling the disease and improve health. Vaccine research is apparently slow, but really did not sleep.
Big profit from each vaccine patent pharmaceutical industry interest, besides of course the price of the vaccine itself. Even now a large number of funds used for the purposes of research and development. The result was they managed to create many new discoveries and innovations.
“Even the little things being done today will certainly achieve great success within the next 10 years. The period could be described as the golden era,” says Emilio Emini, head of vaccine research division of Pfizer.
The vaccine is now seen as essential for the growth of the pharmaceutical industry, primarily to offset the slow growth of prescription sales. If prescription drugs are predicted to grow in three to five years, sales of the vaccine was estimated twice as high.
According to market research institute, Kalorama Information, from 19 billion U.S. dollars last year, sales of vaccines will increase to 39 billion dollars in the year 2013. “Interestingly, when 25 years are still struggling in the research, has now become a real money,” said Robin Robertson, director of U.S. Biomedical Advanced Research Development Authority.
Jump in profit is due to a little more extensive use of the vaccine along with mandatory immunization recommendations for infants issued by the government. We have too many vaccines are required for adults.
In contrast to conventional drugs used to cure the disease, the vaccine used to prevent infection by increasing the natural immune system to fight the entry of the disease. The vaccine is created from viruses, bacteria, which have killed or weakened so that they generally cause infection.
In the future, vaccines will not only be limited to the injection, but also in the form of a sticker attached to the skin, pills, or nasal spray. So far the British pharmaceutical company, GlaxoSmithKline is still the largest vaccine maker in the world, defeated Merck & Co..
Unfortunately, advances in biotechnology innovation is still dominated by developed countries. The defeat of the countries in Asia in the field to compete in this innovative advances made this country, as a marketing target of the vaccine, which of course sold at a high price.
